LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research return on equity (ROE)

Lam Research's return on equity is 60.75%: net income of 8.45B USD over the last twelve months on shareholders' equity of 13.91B USD.

Today
60.75%
Average, 5 years
57.10%
Low, 5 years
42.06%
High, 5 years
75.35%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 8.45B ÷ 13.91B = 60.75%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Lam Research's return on equity so high?

Net margin
31.3%
profit on each dollar of sales
Asset turnover
0.99×
sales on each dollar of assets
Equity multiplier
1.89×
assets on each dollar of equity
Return on equity
58.3%
FY2026
  • FY202631.3% × 0.99 × 1.89 = 58.3%
  • FY202529.1% × 0.86 × 2.16 = 54.3%
  • FY202425.7% × 0.80 × 2.20 = 44.8%
  • FY202325.9% × 0.93 × 2.29 = 54.9%
  • FY202226.7% × 1.00 × 2.74 = 73.4%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today60.75%8.45B13.91B
FY202628 Jun 202658.26%7.27B12.47B
FY202529 Jun 202554.33%5.36B9.86B
FY202430 Jun 202444.82%3.83B8.54B
FY202325 Jun 202354.94%4.51B8.21B
FY202226 Jun 202273.35%4.61B6.28B
FY202127 Jun 202164.85%3.91B6.03B
FY202028 Jun 202043.44%2.25B5.18B
FY201930 Jun 201946.40%2.19B4.72B
FY201830 Jun 201836.18%2.38B6.58B
FY201730 Jun 201724.30%1.70B6.99B
FY201630 Jun 201614.98%914.05M6.10B
FY201530 Jun 201512.27%655.58M5.34B
FY201430 Jun 201412.13%632.29M5.21B
FY201330 Jun 20132.44%113.88M4.68B
FY201230 Jun 20123.17%168.72M5.32B
FY201130 Jun 201129.30%723.75M2.47B
FY201030 Jun 201019.61%346.67M1.77B
FY200930 Jun 2009-20.79%-302.15M1.45B
FY200830 Jun 200824.70%439.35M1.78B
FY200730 Jun 200758.30%685.82M1.18B
FY200630 Jun 200623.83%335.76M1.41B
FY200530 Jun 200528.06%299.34M1.07B
FY200430 Jun 200410.21%82.99M812.47M
FY200330 Jun 2003-1.19%-7.74M649.08M
FY200230 Jun 2002-13.34%-90.05M675.06M
FY200130 Jun 20017.31%52.11M712.37M
FY200030 Jun 200032.22%204.76M635.42M
FY199930 Jun 1999-27.61%-112.91M408.96M
FY199830 Jun 1998-27.64%-144.60M523.09M
FY199730 Jun 1997-5.69%-33.63M590.64M
FY199630 Jun 199623.14%141.09M609.80M
FY199530 Jun 199522.57%89.21M395.26M
FY199430 Jun 199421.38%37.80M176.80M
FY199330 Jun 199314.50%18.90M130.30M
FY199230 Jun 19929.29%9.90M106.60M
FY199130 Jun 19919.95%6.10M61.30M
FY199030 Jun 1990-16.18%-8.80M54.40M
FY198930 Jun 198916.29%9.30M57.10M
FY198830 Jun 19884.93%2.30M46.70M
FY198730 Jun 1987-6.78%-2.70M39.80M
FY198630 Jun 19864.00%1.70M42.50M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Lam Research's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.